
Shenzhen Liying Biotechnology
Specializes in protein design and modification for synthetic biology and biopharmaceutical applications.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | CNY100m | Series A |
Total Funding | 000k |
Related Content
Lybio.com specializes in protein design and modification, offering high-quality and efficient research and development services for a wide range of protein applications. The company synthesizes protein materials and provides tailored solutions for various industries, including pharmaceuticals, biotechnology, and healthcare. The core technology founders and team members boast over a decade of experience from prestigious institutions such as the University of Oxford, the University of Cambridge, and the Francis Crick Institution. Lybio.com serves clients ranging from academic researchers to commercial enterprises, operating in the global biotechnology market. The business model revolves around providing contract research organization (CRO) and contract development and manufacturing organization (CDMO) services, generating revenue through project-based contracts and long-term partnerships.
Keywords: protein design, protein modification, R&D services, protein synthesis, biotechnology, pharmaceuticals, healthcare, CRO, CDMO, research expertise.